Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Phathom Pharmaceuticals is a biopharmaceutical company.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
Ambros Therapeutics is a clinical-stage biotechnology company.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.
Quell Therapeutics is a cell therapy company
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Janus Henderson Investors has invested in 228 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Life Science. The firm invests across 15 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $32.6B.
Janus Henderson Investors's average investment size is $150.1M across its portfolio of 228 companies.
Recent Janus Henderson Investors portfolio additions include TwinStrand Biosciences, Diagonal Therapeutics, Phathom Pharmaceuticals, Synthekine, Vaxcyte. These companies were founded in 2020 or later.